St. Luke's Cancer Center - Anderson Campus is a clinical research site located in Easton, Pennsylvania, United States 18045.
Crixeo Health Trust Score: 63/100 (FAIR). This profile has not yet been claimed by the site owner.
St. Luke's Cancer Center - Anderson Campus has participated in 3 clinical trials.
Therapeutic areas: Stomatitis, Metastatic or Unresectable Cutaneous Melanoma, Melanoma.
Sponsors: Enzychem Lifesciences Corporation, Pfizer, Bristol-Myers Squibb.
Trust Score: 63/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
St. Luke's Cancer Center - Anderson Campus has a Crixeo Trust Score of 63/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
St. Luke's Cancer Center - Anderson Campus has 3 clinical trials on record. Their work covers Stomatitis, Metastatic or Unresectable Cutaneous Melanoma, Melanoma.
St. Luke's Cancer Center - Anderson Campus has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.